Clinical Trial Update: Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Lometrexol plus folic acid for stage IIIB or stage IV non-small cell lung cancer; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lometrexol (Lometrexol)
• folic acid (folic acid)

Snippet

Sponsor: Tularik | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN